Interferon
This page covers all Interferon drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-alfa receptor (IFNAR), IFNAR, Interferon-alpha receptor (IFNAR).
Targets
Interferon-alfa receptor (IFNAR) · IFNAR · Interferon-alpha receptor (IFNAR) · IFN-beta receptor · Interferon-alpha/beta receptor (IFNAR) · Interferon receptor · Interferon-alpha receptor · Type I interferon receptor (IFNAR) · Interferon-beta receptor (IFNAR) · Interferon-beta receptor (IFNAR1/IFNAR2)
Marketed (1)
- pegylated interferon-alfa · Third Affiliated Hospital, Sun Yat-Sen University · Immunology, Virology, Oncology
Pegylated interferon-alfa is a modified form of interferon-alfa that binds to interferon-alfa receptors on immune cells to enhance antiviral and anti-tumor immune responses.
Phase 3 pipeline (22)
- PEG-IFNa 2a · IRCCS San Raffaele · Oncology
PEG-IFNa 2a is a pegylated form of interferon alpha-2a, which works by stimulating the body's immune system to fight viral infections and cancer cells. - High-Dose IFN-a2b · Peking University Cancer Hospital & Institute · Oncology
High-dose interferon-alpha-2b activates the innate and adaptive immune system to enhance anti-tumor immunity and inhibit tumor cell proliferation. - rhIFN beta-1b · Nuron Biotech Inc. · Immunology
rhIFN beta-1b is a recombinant form of interferon beta-1b that modulates the immune system to reduce inflammation in the central nervous system. - SNG001 · Synairgen Research Ltd. · Respiratory
SNG001 is an inhaled interferon beta-1a, which works by stimulating the body's immune response to fight off respiratory viruses. - IFN beta(24 weeks) · Tanabe Pharma Corporation · Immunology
Interferon beta activates innate immune responses by binding to interferon-beta receptors on immune cells, enhancing antiviral and immunomodulatory activity. - Ypeginterferon alfa-2b · Xiamen Amoytop Biotech Co., Ltd. · Oncology, Infectious Diseases
Ypeginterferon alfa-2b is a recombinant form of interferon alfa-2b used to modulate the immune system. - recombinant interferon alfa-2b · Case Comprehensive Cancer Center · Oncology
Recombinant interferon alfa-2b works by stimulating the body's immune system to fight viral infections and cancer. - Rebif New Formulation Non Titrated · EMD Serono · Immunology
Rebif New Formulation Non Titrated is an interferon beta-1a formulation used to treat multiple sclerosis. - albumin interferon alfa-2b · Human Genome Sciences Inc. · Oncology
Albumin interferon alfa-2b is a recombinant form of interferon alfa-2b fused to human albumin, which is used to enhance its half-life and therapeutic effects. - Interferon-beta-1a FBS-free/HSA-free · EMD Serono · Immunology
Interferon-beta-1a activates interferon-alpha/beta receptors on immune cells to enhance antiviral and immunomodulatory responses. - Peginterferon α2b · University of Jena · Infectious Diseases
Peginterferon α2b works by stimulating the body's immune system to fight viral infections. - Interferon beta type 1a · Biogen · Immunology
Interferon beta-1a binds to type I interferon receptors on immune cells to enhance antiviral and immunomodulatory responses, reducing inflammation and immune cell infiltration into the central nervous system. - Interferon Beta-1A Prefilled Syringe · Cinnagen · Immunology
Interferon Beta-1A binds to type I interferon receptors on cell surfaces to activate antiviral and immunomodulatory pathways. - interferon-a-2a · Hoffmann-La Roche · Oncology
Interferon-alpha-2a works by stimulating the body's immune system to fight viral infections and cancer. - Peginterferon alfa-2b (PEG2b) · Merck Sharp & Dohme LLC · Virology
Peginterferon alfa-2b (PEG2b) is a pegylated form of interferon alfa-2b, which works by stimulating the body's immune system to fight viral infections. - Rebif® new formulation (RNF) · EMD Serono Research & Development Institute, Inc. · Immunology
Rebif new formulation (RNF) is an interferon beta-1a used to treat multiple sclerosis. - Placebo to interferon beta-1a · Celgene · Immunology
Interferon beta-1a activates interferon signaling pathways to modulate immune responses and reduce inflammatory activity. - Pegylated interferon beta-1a · Cinnagen · Immunology
Pegylated interferon beta-1a works by stimulating the body's immune system to fight multiple sclerosis. - Interferon β-1a 30 µg · Novartis · Immunology
Interferon β-1a activates interferon-beta receptors on immune cells to enhance antiviral and immunomodulatory responses, reducing inflammation and immune-mediated demyelination. - Rebif New Formulation Titrated · EMD Serono · Immunology
Rebif New Formulation Titrated is an interferon beta-1a formulation used to treat multiple sclerosis. - IFN beta(48 weeks) · Tanabe Pharma Corporation · Immunology
Interferon beta activates innate immune responses by binding to interferon-beta receptors on immune cells, enhancing antiviral and immunomodulatory activity. - Pegylated Interferon α2 · Sheikh Zayed Medical College · Immunology
Pegylated Interferon α2 activates innate immune responses by binding to interferon-alpha receptors, enhancing antiviral and anti-proliferative activity.
Phase 2 pipeline (5)
- BAY86-5046_Interferon-beta-1b · Bayer · Neurology
Interferon-beta-1b binds to the interferon-alpha/beta receptor, activating a signaling cascade that modulates immune responses. - Alpha Interferon · Sunnybrook Health Sciences Centre · Oncology, Infectious Diseases
Alpha Interferon works by stimulating the body's immune system to fight viral infections and cancer. - Interferon-β [IFN-β] · Sanofi · Immunology
Interferon-β binds to the interferon receptor, activating a signaling cascade that modulates the immune response. - Actimmune Registry · InterMune · Immunology
Interferon gamma-1b is a recombinant form of the human interferon gamma protein that helps to stimulate the immune system to fight infections and diseases. - IFN-alpha · Active Biotech AB · Oncology
Interferes with viral replication by binding to the cell surface receptor for the virus.